Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|21|2609-2625

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.21, 2013-01, pp. : 2609-2625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Protein Tyrosine Phosphatase 1B as a Potential Treatment of Diabetes and Obesity

By  

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3481-3504

Bentham Science Publishers

Access to resources Recommend Favorite

Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin Resistance

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 265-275

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Tyrosine Phosphatase 1B: A Novel Target for Type 2 Diabetes and Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 7, 2003-03 ,pp. : 749-757

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity

By  

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 551-575

Bentham Science Publishers

Access to resources Recommend Favorite

Protein-Tyrosine Phosphatase 1B as a Potential Drug Target for Obesity

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 299-304

Bentham Science Publishers

Access to resources Recommend Favorite